Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
J Card Fail. 2021 Apr;27(4):445-452. doi: 10.1016/j.cardfail.2020.12.006. Epub 2021 Jan 9.
Findings from heart failure (HF) studies linking diuresis-related weight loss to clinical decongestion and outcomes are mixed. Differential responses of interstitial and intravascular volume compartments to diuretic therapy and heterogeneity in volume profiles may confound the clinical interpretation of weight loss in patients with HF.
Data were prospectively collected in hospitalized patients requiring diuresis. Plasma volume (PV) was measured using I-131-labelled albumin indicator-dilution methodology. The cohort was stratified by tertiles of weight loss and analyzed for interstitial fluid loss relative to changes in PV and HF-related morality or first rehospitalization. Among 92 patients, the admission PV was expanded +42% (4.7 ± 1.2 L) above normal with significant variability (14% normal PV, 18% mild-moderate expansion, and 68% with large PV expansion [>+25% above normal]). With diuresis there were proportional decreases in interstitial volume (-6.5 ± 4.4%) and PV (-7.5 ± 11%); however, absolute decreases in the PV (-254 mL, interquartile range -11 to -583 mL) were less than 10% of interstitial volume loss (-5040 mL, interquartile range -2800 to -7989 mL); greater interstitial fluid loss did not translate into better outcomes (log-rank P = .430).
Diuresis-related decreases in weight reflect fluid loss from the interstitial compartment with only minor changes in the PV and without an impact on outcomes. Further, the degree of PV expansion at hospital admission does not drive the magnitude of the diuresis response, even with a wide spectrum of body weights; interstitial fluid overload is preferentially targeted and PV relatively preserved. Therefore, greater interstitial fluid loss reflects clinical decongestion, but not better outcomes, and a limited association with intravascular volume profiles potentially confounding weight loss as a prognostic metric in HF.
心力衰竭(HF)研究中利尿剂相关体重减轻与临床消肿和结局之间的关联结果不一。利尿剂治疗对间质和血管内容积区室的反应不同以及容积谱的异质性可能使 HF 患者体重减轻的临床解释复杂化。
前瞻性收集需要利尿剂治疗的住院患者的数据。使用 I-131 标记白蛋白指示剂稀释法测量血浆容量(PV)。根据体重减轻的三分位数将队列分层,并分析间质液丢失相对于 PV 的变化与 HF 相关死亡率或首次再入院的关系。在 92 例患者中,入院时的 PV 比正常水平增加了 42%(4.7±1.2 L),且差异很大(正常 PV 的 14%,轻度中度扩张的 18%,PV 大量扩张的 68%[>+25%高于正常])。利尿剂治疗后,间质容积减少了 6.5±4.4%(-6.5±4.4%),PV 减少了 7.5±11%(-7.5±11%);然而,PV 的绝对减少量(-254 mL,四分位距-11 至-583 mL)小于间质容积丢失量的 10%(-5040 mL,四分位距-2800 至-7989 mL);间质液丢失量的增加并没有转化为更好的结局(对数秩检验 P=0.430)。
利尿剂相关体重减轻反映了间质腔中的液体丢失,只有 PV 发生微小变化,对结局没有影响。此外,入院时 PV 的扩张程度并不能驱动利尿反应的幅度,即使体重差异很大;间质液超负荷被优先靶向,而 PV 相对保留。因此,更大的间质液丢失反映了临床消肿,但不能反映更好的结局,并且与血管内容积谱的关联有限,可能使 HF 中体重减轻作为预后指标变得复杂。